In the 2025 financial year, Datwyler generated revenue of CHF 1'100.5 million. Adjusted for negative currency effects of -3.7%, the company achieved organic growth of 3.1%. Due to these currency effects, reported revenue was overall 0.6% below the prior-year level.

Datwyler announced a collaboration with LTS Device Technologies, a developer of smart wearable devices for drug delivery, and Stevanato Group

Datwyler has signed an agreement to acquire 51% of Capsul’Invest SA und Brain Corp SA (together operating as Capsul’in), a leading provider of aluminum coffee capsule solutions headquartered in Luxembourg with annual revenues of approximately EUR 90 million.

Wearables have become a major driver of innovation in personalized healthcare in recent years. Learn more about how we turn insights into solutions through our solution design approach on the example of SoftPulse(sup:TM) Flex

Datwyler gained momentum in the first half of 2025 despite a challenging environment.

Datwyler strengthens its market position and drives growth by commencing serial supply of premium components for GLP-1 therapies, reflecting its strategic investments and early-stage development partnerships within the rapidly expanding injectable drug market.

Datwyler's specialized sealing solutions ensure the efficient and reliable operation of electrolyzers and auxiliary systems.

Datwyler slightly increased its EBIT margin in 2024 despite weak markets and a slight decline in revenue. The transformation program «ForwardNow» will accelerate the planned profitable growth.

Datwyler is launching a transformation program for the period 2025 to 2027 to accelerate revenue and profitability growth.

Sealing influences the mechanical stability and thermal management of the battery, which is essential for maintaining optimal performance under various operating conditions.

Datwyler announces the expansion of its NeoFlex™ range of coated plungers with new sizes for containers aimed at large-volume auto-injectors and wearable devices.

As the world pivots towards sustainable energy systems, green hydrogen is rapidly becoming a cornerstone of future energy strategies.

Despite a weak market environment, Datwyler improved its profitability and further strengthened its project pipeline in the first half of 2024.

As announced, Volker Cwielong took over as CEO of Datwyler on 1 April 2024. Dirk Lambrecht, who had held the position since 2017, stepped down at the end of March 2024.

Momentive, Datwyler and BSC Computer are collaborating on the industrial market launch of solutions focused on the innovation of 'Dielectric Elastomer Actuators'.

Datwyler was able to maintain revenue in 2023 despite the loss of the Covid business and destocking by customers. The strong project pipeline provides the basis for scaling the business model.

Datwyler is teaming up with Conserva UK to establish an unrivaled supply chain for pharmaceutical primary packaging in the UK market.

Datwyler has expanded its capabilities to support customers transitioning to hydrogen fuel cell technology.